Primordial Dyslipidemia Prevention In Childhood Critical For Reducing Atherosclerosis Development
- byDoctor News Daily Team
- 29 July, 2025
- 0 Comments
- 0 Mins

Finland: A recent study published in the Journal of the American Heart Association has suggested that treating or preventing dyslipidaemia in childhood may be critical for avoiding later atherosclerosis.
The study found that the risk for atherosclerosis remains elevated even in people whose dyslipidaemia does not last beyond childhood.
The researchers wrote, "even if resolved by adulthood, childhood dyslipidemia is a risk factor for adult carotid plaque. Also, childhood lipids are associated with plaque size in people with carotid plaque." The findings underscore the importance of primordial dyslipidemia prevention in childhood to reduce atherosclerosis development.
Previous studies have shown an association between childhood exposure to dyslipidemia and adult atherosclerosis. Still, there is no clarity on whether the long-term risk tied to dyslipidemia is attenuated on its resolution by adulthood. Juhani S. Koskinen, University of Turku, Turku, Finland, and colleagues aimed to address this question by assessing the links between childhood and adult dyslipidemia on carotid atherosclerotic plaques in adulthood.
The Cardiovascular Risk in Young Finns Study is a prospective follow‐up of children initiated in 1980; since then, follow-up studies have been regularly conducted. Carotid ultrasounds were performed on 2643 participants in 2001 and 2007 at the mean age of 36 years to identify plaque areas and carotid plaques.
They exploited various risk factor measurements for childhood lipids to determine each lipid's cumulative burden during childhood. Participants were categorized into four groups based on their adult and childhood dyslipidemia status: persistent, resolved, incident, and no dyslipidemia (reference). Linear regression models were used to study the association of serum lipids with plaque area among individuals with carotid plaque.
The study led to the following findings:
The prevalence of plaque was 3.3% (N=88). In models adjusted for sex, age and nonlipid cardiovascular risk factors, the relative risk for the carotid plaque was 2.34 for incident adult dyslipidemia, 3.00 for dyslipidemia resolved by adulthood, and 5.23 for persistent dyslipidemia.
Carotid plaque area was correlated with childhood total, low‐density lipoprotein, and non–high‐density lipoprotein cholesterol levels.
The findings show that even if resolved by adulthood, childhood dyslipidemia is a risk factor for carotid artery plaque. Childhood lipids are also independently associated with the level of adulthood atherosclerosis observed decades later.
"The results emphasize the role of childhood exposures for adult cardiovascular health," the researchers conclude.
"They indicate the importance of primordial prevention targeted to lipids from an early age, as subsequent prevention left to adulthood is likely too late to limit the risk that has accumulated earlier in life."
Reference:
Koskinen JS, Kytö V, Juonala M, Viikari JSA, Nevalainen J, Kähönen M, Lehtimäki T, Hutri-Kähönen N, Laitinen TP, Tossavainen P, Jokinen E, Magnussen CG, Raitakari OT. Childhood Dyslipidemia and Carotid Atherosclerotic Plaque in Adulthood: The Cardiovascular Risk in Young Finns Study. J Am Heart Assoc. 2023 Mar 16:e027586. doi: 10.1161/JAHA.122.027586. Epub ahead of print. PMID: 36927037.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Chennai: Fortis Healthcare Opens 250-Bedded 2nd Mu...
- 06 July, 2025
New Lab-On-A-Chip, Cheaper, Faster, On The Spot Di...
- 06 July, 2025
Steroids And Plasma Exchange Do Not Alter Prognosi...
- 14 February, 2020
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!